Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD2811 Monotherapy in Relapsed Small Cell Lung Cancer
NCT03366675Phase 2Terminated
- Sponsor
- Samsung Medical Center
- Start
- Dec 2017
- Primary completion
- Oct 2018
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of defosbarasertib in small cell lung cancer (SCLC), sponsored by Samsung Medical Center. Started Dec 2017; status: terminated.
02
Drugs
defosbarasertib
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT03366675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03366675.